Methotrexate and the Risk of Dementia: A Two-Sample Mendelian Randomization Study

ConclusionThe findings of this mendelian randomization (MR) study suggest a potential causal effect of methotrexate use on the risk of dementia. However, further research is needed to validate these findings and explore the underlying mechanisms. Since methotrexate is widely prescribed for various autoimmune diseases, a better understanding of its potential impact on dementia risk is crucial for optimizing treatment strategies and addressing potential adverse effects.
Source: Neurology and Therapy - Category: Neurology Source Type: research